amplius GmbH – Screening Technologies and Analytical Measurement
At amplius we develop enzymatic and cellular assays e.g. for drug-screening purposes. Due to improvements in the area of automation new structures and their biological activities can be identified faster and more doubtlessly.
BioGenes GmbH
BioGenes develops polyclonal antibodies in different species (rabbit, chicken, mouse and goat), and monoclonal antibodies using hybridoma and cell culture techniques (D) [D, E]
ensymm: Technology Transfer for Biotechnology and Biotech Services
Ensymm provides its industrial partners with biotechnical projects and ideas created by researchers.ensymm consults it’s customers and connect foreign biotech companies (with their products) to appropriate distributors for the European market (D) [E]
The author- or copyrights of the listed Internet pages are held by the respective authors or site operators, who are also responsible for the content of the presentations.